Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Sheng

Showing results (631-640 of 664) with videos related to

Pageof 67
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2016
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014Monzr M Al Malki, Mary Horowitz, Rupert Handgretinger, et al.
International Journal of Antimicrobial Agents|July 5, 2022
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimensGuan-Jhou Chen, Hsin-Yun Sun, Ling-Ya Chen, et al.
Signal Transduction and Targeted Therapy|May 7, 2021
HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patientsRuonan Xu, Ji-Yuan Zhang, Bo Tu, et al.
Theranostics|May 14, 2025
Erratum: Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation: ErratumYun-Xin Lu, Qi-Nian Wu, Dong-Liang Chen, et al.
Theranostics|March 7, 2018
Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox ModulationYun-Xin Lu, Qi-Nian Wu, Dong-Liang Chen, et al.
Emerging Microbes & Infections|June 27, 2024
HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a studyTao Yang, Zhiman Xie, Zhe Xu, et al.
Open Forum Infectious Diseases|August 5, 2022
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR StudyChen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng, et al.
Nature Communications|January 16, 2026
Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolismHewen Jiang, Xiaohui Tao, Sifan Yu, et al.
Neuroscience Bulletin|November 15, 2017
Comorbidity Burden of Dementia: A Hospital-Based Retrospective Study from 2003 to 2012 in Seven Cities in ChinaQing-Hua Wang, Xin Wang, Xian-Le Bu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-upMei Guo, Kai-Xun Hu, Guang-Xian Liu, et al.
Pageof 67

Showing results (631-640 of 664) with videos related to

Sort By:
Pageof 67
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2016
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014Monzr M Al Malki, Mary Horowitz, Rupert Handgretinger, et al.
International Journal of Antimicrobial Agents|July 5, 2022
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimensGuan-Jhou Chen, Hsin-Yun Sun, Ling-Ya Chen, et al.
Signal Transduction and Targeted Therapy|May 7, 2021
HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patientsRuonan Xu, Ji-Yuan Zhang, Bo Tu, et al.
Theranostics|May 14, 2025
Erratum: Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation: ErratumYun-Xin Lu, Qi-Nian Wu, Dong-Liang Chen, et al.
Theranostics|March 7, 2018
Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox ModulationYun-Xin Lu, Qi-Nian Wu, Dong-Liang Chen, et al.
Emerging Microbes & Infections|June 27, 2024
HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a studyTao Yang, Zhiman Xie, Zhe Xu, et al.
Open Forum Infectious Diseases|August 5, 2022
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR StudyChen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng, et al.
Nature Communications|January 16, 2026
Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolismHewen Jiang, Xiaohui Tao, Sifan Yu, et al.
Neuroscience Bulletin|November 15, 2017
Comorbidity Burden of Dementia: A Hospital-Based Retrospective Study from 2003 to 2012 in Seven Cities in ChinaQing-Hua Wang, Xin Wang, Xian-Le Bu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-upMei Guo, Kai-Xun Hu, Guang-Xian Liu, et al.
Pageof 67